---
document_datetime: 2024-07-25 12:13:09
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/byfavo-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: byfavo-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.2370838
conversion_datetime: 2025-12-27 14:02:00.265528
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Byfavo

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| T/0022               | Transfer of Marketing Authorisation                                                                                                                       | 05/07/2024                          | 22/07/2024                                  | SmPC, Labelling and PL           |           |
| IA/0023              | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits | 27/06/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0021/G         | This was an application for a group of variations. B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   | 03/06/2024   | 22/07/2024   | Annex II and PL   |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------|-----------------------------------|
| IA/0019/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 27/03/2024   | n/a          |                   |                                   |
| PSUSA/10924 /202307 | Periodic Safety Update EU Single assessment - remimazolam                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 08/02/2024   | n/a          |                   | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0018             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                           | 08/11/2023   | n/a        |      |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------|-----------------------------------|
| IB/0016/G           | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor                                                                                                                            | 01/09/2023   | n/a        |      |                                   |
| PSUSA/10924 /202301 | Periodic Safety Update EU Single assessment - remimazolam                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 31/08/2023   | n/a        |      | PRAC Recommendation - maintenance |
| IB/0014/G           | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process | 15/06/2023   | 25/01/2024 | SmPC |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0015/G   | This was an application for a group of variations. B.II.f.z - Stability of FP - Other variation B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                                  | 31/05/2023   | n/a        |                        |                     |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------------|
| IAIN/0013/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - control/testing | 17/04/2023   | 25/01/2024 | Annex II and PL        | Not including batch |
|             | B.II.f.z - Stability of FP - Other variation                                                                                                                                                                                                                                                                                                                             | 12/04/2023   | n/a        |                        | IB/0011             |
| X/0002      | Annex I_2.(c) Change or addition of a new strength/potency Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                                                                                                                                                 | 26/01/2023   | 31/03/2023 | SmPC, Labelling and PL |                     |
| IAIN/0010   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                       | 14/02/2023   | n/a        |                        |                     |
| IAIN/0009   | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer                                                                                                                                                                                                                          | 14/02/2023   | 25/01/2024 | Annex II and PL        |                     |

<div style=\"page-break-after: always\"></div>

|                     | responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |             |                                                                                                                        |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10924 /202207 | Periodic Safety Update EU Single assessment - remimazolam                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 09/02/2023 | n/a        |             | PRAC Recommendation - maintenance                                                                                      |
| IB/0008/G           | This was an application for a group of variations. B.I.d.1.b.3 - Stability of AS - Change in the storage conditions - Change in storage conditions of the AS B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 10/01/2023 | n/a        |             |                                                                                                                        |
| PSUSA/10924 /202201 | Periodic Safety Update EU Single assessment - remimazolam                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 15/09/2022 | 18/11/2022 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                         |            |            |                        | PSUSA/10924/202201.                                                                                                                        |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| T/0006              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                     | 21/09/2022 | 07/10/2022 | SmPC, Labelling and PL |                                                                                                                                            |
| IA/0005/G           | This was an application for a group of variations. B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                    | 06/07/2022 | n/a        |                        |                                                                                                                                            |
| IA/0004/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 24/06/2022 | n/a        |                        |                                                                                                                                            |
| PSUSA/10924 /202107 | Periodic Safety Update EU Single assessment - remimazolam                                                                                                                                                                                                                                               | 24/02/2022 | 25/04/2022 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10924/202107. |